Holen Sie sich die Stockscreener-App
11.68
7.06%
0.77
Handel nachbörslich:
11.78
0.10
+0.86%
Schlusskurs vom Vortag:
$10.91
Offen:
$10.76
24-Stunden-Volumen:
54,552
Relative Volume:
1.92
Marktkapitalisierung:
$23.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-37.68
EPS:
-0.31
Netto-Cashflow:
$-3.95M
1W Leistung:
+6.67%
1M Leistung:
-9.60%
6M Leistung:
-39.13%
1J Leistung:
+55.76%
1-Tages-Spanne:
$10.64
$12.26
1-Wochen-Bereich:
$10.14
$12.26
52-Wochen-Spanne:
$5.70
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Firmenname
Cadrenal Therapeutics Inc
Sektor
Branche
Telefon
904-300-0701
Adresse
822 A1A NORTH, PONTE VEDRA
Vergleichen Sie CVKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
11.68 | 22.33M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-18 | Eingeleitet | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten
Signal strength of CLSD stock in tech scannersFree Pattern Breakout Entry Stock Forecast - Newser
Will LILAK face regulatory challengesHigh ROE Investment Ideas - sisain.net
Tools to monitor Cadrenal Therapeutics Inc. recovery probabilityFast Movement Forecast for Trading Success - Newser
Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - BioSpace
Cadrenal Therapeutics Advances Tecarfarin Development - TipRanks
How to forecast ABIG trends using time seriesFree Low Volatility Stable Growth Picks - Newser
Visual analytics tools that track Cadrenal Therapeutics Inc. performanceWeekly Market Direction and Sector Summary - Newser
Cadrenal (CVKD) Issues Q2 2025 Financial Press Release — 8-K - Stock Titan
Cadrenal Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Real time breakdown of Cadrenal Therapeutics Inc. stock performanceFree Swing Trading Plan With Smart Signals - Newser
Order flow analysis tools used on Cadrenal Therapeutics Inc.Daily Trade Setup Forecast with Confidence - Newser
Custom strategy builders for tracking Cadrenal Therapeutics Inc.Long Term Stock Planner with Safety Checks - Newser
Earnings visualization tools for Cadrenal Therapeutics Inc.Real Stock Picks With Setup Verification - Newser
Analyzing net buyer seller activity in Cadrenal Therapeutics Inc.Free AI-Powered Trade Planning with Indicators - Newser
TZUP Stock Chart Analysis: Bullish or Bearish Pattern FormingTrade Plan With Low Risk High Return - Newser
Is ECDA a Top Dividend Stock to Watch in 2025Pattern Breakout Tracker with Screener Tools - Newser
Using economic indicators to assess Cadrenal Therapeutics Inc. potentialShort-Term Sector Movement Forecast Generator - Newser
Main Inc. stock performs during market volatilityDaily Technical Forecast for Quick Gains - Newser
Cadrenal Therapeutics Inc. stock outlook for YEARChart Driven Entry Timing for Swing Trades - Newser
How volatile is SBXD.WS stock10-Bagger Stock Radar - mustnews.co.kr
How Cadrenal Therapeutics Inc. stock performs during market volatilityInvestment Timeline and ROI Summary Report - Newser
Real time pattern detection on CVLT stockExit Strategy Guide With Risk Control Plan - Newser
Can CDIOW hit a new high this monthTechnical Setup Guide for Daily Watchlist - Newser
How to interpret RSI for GCT Semiconductor Holding Inc. stockSummary of Trade Cycles in 5-Year Range - Newser
Is RITM.PRD a candidate for recovery playWeekly Breakout Forecast with Entry Zones - Newser
New Product Launches: Will They Boost TuHURA Biosciences Inc. Stock in 2025Weekly Trend Screener with Momentum Picks - Newser
Can you recover from losses in Exicure Inc.3-Year Equity Summary With Setup Insights - Newser
Using data models to predict Cadrenal Therapeutics Inc. stock movementTrade Flow Monitor with Volume Tracker - Newser
Long term hold vs stop loss in Cadrenal Therapeutics Inc.Multi-Year Investment Performance Summary Report - Newser
Will Nordic American Tankers Limited stock go up soonShort-Term Sector Movement Forecast Generator - Newser
What to do if you’re stuck in Nvni Group Limited Equity WarrantWeekly Setup Summary for Risk Controlled Trades - Newser
Is Anterix Inc. still worth holding after the dipFree ROI Boosting Trade Opportunity Calendar - Newser
Cadrenal Therapeutics to Initiate Tecarfarin Clinical Trial - TipRanks
Cadrenal Therapeutics Announces Clinical Trial Initiation Plans For Tecarfarin In Patients With End-Stage Kidney Disease (Eskd) Transitioning To Dialysis - TradingView
Ponte Vedra-based Cadrenal Therapeutics to begin late-stage trial for kidney drug - The Business Journals
Cadrenal Therapeutics (CVKD) Projected to Post Quarterly Earnings on Wednesday - Defense World
Cadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with End-Stage Kidney Disease (ESKD) Transitioning to Dialysis - Lelezard
Key resistance and support levels for Roivant Sciences Ltd.Free Pattern Breakout Entry Stock Forecast - Newser
Best data tools to analyze Helen of Troy Limited stockExpert-Backed High Yield Stock Watchlist - Newser
Price Consolidation Hints at Upcoming Move in Cadrenal Therapeutics Inc.Community Entry Consensus Trade Ideas Shared - beatles.ru
How sentiment analysis helps forecast VALEFree ROI Driven Equity Selection With Safety - Newser
Exit strategy if you’re trapped in Cadrenal Therapeutics Inc.Buy Signal Forecast With Short-Term Data - Newser
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):